Income Statement
ENVERIC BIOSCIENCES, INC.
ENVB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | 39.91 | 43.00 | 48.59 | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | 31.76 | 34.01 | 38.36 | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | 8.15 | 8.98 | 10.24 | - | - | - | - |
|
Operating Expenses
|
8.77 | 9.63 | 16.45 | 27.42 | 64.62 | 5.62 | 14.48 | 16.13 | 22.21 | -0.03 | 0.03 | 0.02 | 0.03 |
|
Research & Development
|
2.78 | 2.84 | 7.25 | 8.03 | 4.79 | 0.17 | - | - | - | - | - | - | - |
|
Selling, General & Administrative
|
5.79 | 6.45 | 8.85 | 11.61 | 20.50 | 5.44 | 12.21 | 10.79 | 18.51 | -0.03 | 0.03 | 0.02 | 0.03 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-8.77 | -9.63 | -16.45 | -27.42 | -64.62 | -5.62 | -6.32 | -7.15 | -11.97 | 0.03 | -0.03 | -0.02 | -0.03 |
|
Non-Operating Income
|
0.00 | 0.07 | -0.81 | 7.46 | 8.19 | 1.25 | 1.11 | -3.40 | 0.50 | 0.07 | -0.03 | 0.00 | 0.00 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | 0.01 | 0.01 | 0.45 | 0.69 | 0.73 | 0.58 | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-8.77 | -9.57 | -17.26 | -19.96 | -56.43 | - | -5.22 | -10.55 | -11.47 | -0.03 | 0.00 | -0.02 | -0.03 |
|
Income Tax Expense
|
0.00 | 0.01 | 0.03 | -1.49 | -7.45 | - | 0.39 | 6.35 | -2.39 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | 0.00 | - | - | - | - |
|
Net Income
|
-8.77 | 19.16 | 34.61 | 36.94 | -48.98 | 4.37 | -5.60 | -16.90 | -9.07 | -0.03 | 0.00 | -0.02 | -0.03 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-8.57 | -9.29 | -16.10 | -27.09 | -63.97 | -5.62 | -4.06 | -4.24 | -8.75 | 0.03 | -0.03 | -0.02 | -0.03 |
|
Earnings Per Share (Basic)
|
-36.24 | -19.04 | -8.09 | -13.00 | - | - | -2.83 | -0.82 | -0.75 | - | - | - | - |
|
Diluted EPS
|
-36.24 | -19.04 | -8.09 | - | - | - | -2.83 | -0.82 | -0.75 | - | - | - | - |
|
Weighted Average Shares
|
0.33 | 0.50 | 2.16 | 1.45 | - | 5.75 | 2.13 | 23.79 | 14.98 | 15.24 | 12.14 | 12.14 | 8.46 |
|
Diluted Weighted Avg Shares
|
0.33 | 0.50 | 2.16 | - | - | - | 2.13 | 23.79 | 14.98 | - | - | - | - |
|
Comprehensive Income
|
-8.76 | -9.60 | -17.49 | -19.31 | -48.83 | - | -6.06 | -19.43 | -11.12 | - | - | - | - |